GOLDSTEIN DOV A MD - 19 Aug 2021 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Sam Backenroth, as attorney-in-fact for Dov A. Goldstein
Issuer symbol
NBSE
Transactions as of
19 Aug 2021
Net transactions value
$0
Form type
4
Filing time
17 Sep 2021, 16:17:32 UTC
Previous filing
21 Jun 2021
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Stock option (right to buy) Award $0 +38,135 $0.000000 38,135 19 Aug 2021 Common Stock 38,135 $3.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares shall vest on the first anniversary of August 19, 2021, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.